Brainstorm Cell Therapeutics Inc
OTC:BCLI
Brainstorm Cell Therapeutics Inc
OTC:BCLI
Price:
0.6
USD
1.69%
Market Closed
Market Cap:
$14.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Brainstorm Cell Therapeutics Inc
OTC:BCLI
|
US |
|
Agrimin Ltd
ASX:AMN
|
AU |
|
Elixinol Wellness Ltd
ASX:EXL
|
AU |
|
G
|
Gentherm Inc
F:QA4A
|
US |
|
W
|
Wonik IPS Co Ltd
KOSDAQ:240810
|
KR |
|
Amplifon SpA
MIL:AMP
|
IT |
|
G
|
Groupe Tera SA
PAR:ALGTR
|
FR |
|
Consolidated Uranium Inc
XTSX:CUR
|
CA |
|
Nova Minerals Ltd
ASX:NVA
|
AU |
|
Vaxcyte Inc
NASDAQ:PCVX
|
US |
|
Incredible Holdings Ltd
SGX:RDR
|
SG |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of BCLI.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BCLI
Multiples-Based Value
Base Case
Not Available
